5 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... #Meningitis #Antibiotics ... #Antimicrobials ... Empiric #Coverage #InfectiousDiseases ... #Pharmacology #
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
Recommendations for specific antimicrobial ... #IDSA #Meningitis ... #Antibiotics #Antimicrobial ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology #
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Antibiogram - Antibiotic ... Resistance Table ... #Resistance #InfectiousDiseases ... #Resistant #Comparison ... #Table #Pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... Dosages of Antimicrobial ... Intraventricular #antibiotics ... #dosing #pharmacology ... ventriculitis #table